FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

40602111000001101: Buprenorphine 5.7mg / Naloxone 1.4mg sublingual tablets sugar free 28 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 11-May 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
68151000001119 Buprenorphine 5.7mg / Naloxone 1.4mg sublingual tablets sugar free 28 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
68161000001116 Buprenorphine 5.7mg / Naloxone 1.4mg sublingual tablets sugar free 28 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Buprenorphine 5.7mg / Naloxone 1.4mg sublingual tablets sugar free 28 tablet Has VMP Buprenorphine 5.7mg / Naloxone 1.4mg sublingual tablets sugar free true Inferred relationship Existential restriction modifier
Buprenorphine 5.7mg / Naloxone 1.4mg sublingual tablets sugar free 28 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Buprenorphine 5.7mg / Naloxone 1.4mg sublingual tablets sugar free 28 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Naloxone true Inferred relationship Existential restriction modifier
Buprenorphine 5.7mg / Naloxone 1.4mg sublingual tablets sugar free 28 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Buprenorphine 5.7mg / Naloxone 1.4mg sublingual tablets sugar free 28 tablet Has dispensed dose form Conventional release sublingual tablet true Inferred relationship Existential restriction modifier
Buprenorphine 5.7mg / Naloxone 1.4mg sublingual tablets sugar free 28 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Buprenorphine true Inferred relationship Existential restriction modifier
Buprenorphine 5.7mg / Naloxone 1.4mg sublingual tablets sugar free 28 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 3 (CD No Register) true Inferred relationship Existential restriction modifier
Buprenorphine 5.7mg / Naloxone 1.4mg sublingual tablets sugar free 28 tablet Has specific active ingredient Buprenorphine hydrochloride true Inferred relationship Existential restriction modifier
Buprenorphine 5.7mg / Naloxone 1.4mg sublingual tablets sugar free 28 tablet Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Buprenorphine 5.7mg / Naloxone 1.4mg sublingual tablets sugar free 28 tablet VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier
Buprenorphine 5.7mg / Naloxone 1.4mg sublingual tablets sugar free 28 tablet Has specific active ingredient Naloxone hydrochloride dihydrate true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Zubsolv 5.7mg/1.4mg sublingual tablets (Accord Healthcare Ltd) 28 tablet 4 x 7 tablets Is a True Buprenorphine 5.7mg / Naloxone 1.4mg sublingual tablets sugar free 28 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start